Loading clinical trials...
Loading clinical trials...
Post-Infectious Bronchiolitis Obliterans (PIBO) is an irreversible obstructive lung disease characterized by subepithelial inflammation and fibrotic narrowing of the bronchioles after lower respirator...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Universitat Internacional de Catalunya
Collaborators
NCT06018766 · Bronchiolitis Obliterans Syndrome, Chronic Lung Allograft Dysfunction, and more
NCT07316829 · Graft Rejection, Kidney Transplantation, and more
NCT02181257 · Bronchiolitis Obliterans Syndrome (BOS)
NCT07434869 · Lung Transplant Failure and Rejection, CLAD, Bronchiolitis Obliterans, and more
NCT03656926 · Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, and more
Hospital Universitario Donostia
Donostia / San Sebastian, Basque Country
Hospital Universitari Vall d'Hebron
Barcelona, Catalonia
Hospital Universitario Infantil Niño Jesús
Madrid
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions